Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-135
Closed -$26K 165
2018
Q4
$26K Buy
135
+101
+297% +$19.7K 0.01% 230
2018
Q3
$7K Sell
34
-20
-37% -$3.94K ﹤0.01% 200
2018
Q2
$10K Buy
54
+20
+59% +$3.54K 0.01% 255
2018
Q1
$6K Hold
34
﹤0.01% 232
2017
Q4
$6K Hold
34
﹤0.01% 243
2017
Q3
$6K Hold
34
﹤0.01% 201
2017
Q2
$6K Hold
34
﹤0.01% 223
2017
Q1
$6K Hold
34
﹤0.01% 198
2016
Q4
$5K Hold
34
0.01% 122
2016
Q3
$6K Hold
34
0.01% 142
2016
Q2
$5K Hold
34
﹤0.01% 167
2016
Q1
$5K Buy
+34
New +$5.05K 0.01% 137
2015
Q4
Sell
-34
Closed -$5K 15
2015
Q3
$5K Hold
34
﹤0.01% 149
2015
Q2
$5K Hold
34
﹤0.01% 210
2015
Q1
$5K Hold
34
0.01% 174
2014
Q4
$5K Buy
+34
New +$5.3K ﹤0.01% 175

Other funds holding AMGN

Ruggie Capital Group's AMGN Position: Q1 2019 in Review

Ruggie Capital Group sold out of Amgen (AMGN) in Q1 2019, closing a stake of 135 shares — an estimated $26K sold.

Ruggie Capital Group first reported a position in AMGN in Q4 2014 and held it in 16 quarters. The position peaked at $26K in Q4 2018. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Ruggie Capital Group reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Ruggie Capital Group sold 135 Amgen shares in Q1 2019, an estimated $26K.
  • Ruggie Capital Group first reported a position in Amgen in Q4 2014 and held it in 16 quarters.
  • Ruggie Capital Group's Amgen position peaked at $26K in Q4 2018.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Ruggie Capital Group's 13F filing for Q1 2019, filed 24 Apr 2019.